The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(3-chlorophenyl)-2-(5-(4-chlorophenyl)isoxazol-3-yl)-2-oxoacetohydrazonoyl cyanide ID: ALA4093887
PubChem CID: 137656098
Max Phase: Preclinical
Molecular Formula: C18H10Cl2N4O2
Molecular Weight: 385.21
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: N#C/C(=N\Nc1cccc(Cl)c1)C(=O)c1cc(-c2ccc(Cl)cc2)on1
Standard InChI: InChI=1S/C18H10Cl2N4O2/c19-12-6-4-11(5-7-12)17-9-15(24-26-17)18(25)16(10-21)23-22-14-3-1-2-13(20)8-14/h1-9,22H/b23-16+
Standard InChI Key: DKZIBEPCWDPRMI-XQNSMLJCSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
8.3562 -18.8903 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3551 -19.7140 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0672 -20.1229 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7769 -19.7135 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7741 -18.8867 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0655 -18.4773 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0630 -17.6560 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.7695 -17.2453 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.7671 -16.4240 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4777 -16.0091 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4752 -15.1878 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.1907 -16.4197 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2756 -17.2346 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0796 -17.4021 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4902 -16.6890 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.9374 -16.0793 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.0508 -16.0164 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3419 -15.6099 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.4177 -18.1510 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9335 -18.8178 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2675 -19.5669 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0854 -19.6505 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5683 -18.9788 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2316 -18.2324 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6429 -20.1220 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
13.4208 -20.3957 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
10 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 1 0
16 12 2 0
17 18 3 0
9 17 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
14 19 1 0
2 25 1 0
22 26 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 385.21Molecular Weight (Monoisotopic): 384.0181AlogP: 4.82#Rotatable Bonds: 5Polar Surface Area: 91.28Molecular Species: ACIDHBA: 6HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 4.86CX Basic pKa: ┄CX LogP: 5.64CX LogD: 3.97Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.39Np Likeness Score: -1.79
References 1. Ye N, Zhu Y, Liu Z, Mei FC, Chen H, Wang P, Cheng X, Zhou J.. (2017) Identification of novel 2-(benzo[d]isoxazol-3-yl)-2-oxo-N-phenylacetohydrazonoyl cyanide analoguesas potent EPAC antagonists., 134 [PMID:28399451 ] [10.1016/j.ejmech.2017.04.001 ]